This site is intended for health professionals only
Saturday 23 February 2019
Share |

Topic: Policy & practice

October 9, 2018
A no-deal Brexit would put a stop to the the falsified medicines directive (FMD) in the UK, the Department of Health and Social Care (DHSC) has said.

A no-deal Brexit would put a stop to the the falsified medicines directive (FMD) in the UK, the Department of Health and Social Care (DHSC) has said.
 

September 7, 2018
‘Hard look’ at gender parity needed as pharmacy’s female workforce set to grow

A ‘hard look’ at gender parity issues will be vital as the proportion of women working in pharmacy increases, a representative body for the sector has warned.
 

August 14, 2018
The prescribing safety assessment (PSA) could benefit pre-registration pharmacy students who want to become independent prescribers, a study has concluded.

The prescribing safety assessment (PSA) could benefit UK pre-registration pharmacy students who want to become independent prescribers, a study has concluded.
 
The PSA is a 60-minute evaluation of 30 questions on writing and reviewing new prescriptions, calculating drug doses and identifying and avoiding adverse drug reactions and medication errors, among others.
 

July 18, 2018
The UK’s National Health Service turned 70 this month, and while we celebrate the achievements of one of the nation’s most valuable institutions, it’s also the perfect opportunity to pinpoint the role that pharmacy has played in the NHS during those decades.

The role of pharmacists in the NHS has, unsurprisingly, evolved quite a bit since its inception. Growing from what was originally a supply service to become a clinical practice in hospitals, and with a range of new roles in primary care, pharmacists are now recognised as a valuable part of the multidisciplinary clinical team.
 

January 19, 2018
Managed access agreement to be developed in parallel to urgently provide effective new treatment to patients in England

The National Institute for Health and Care Excellence (NICE) has formally invited Biogen to submit Spinraza (nusinersen), the first and only disease-modifying treatment for 5q spinal muscular atrophy (SMA), for assessment via the Single Technology Appraisal (STA) route.

 

January 9, 2018
Applicable across acute hospital, mental health, private, community service, prison, hospice and ambulance settings in Great Britain, the new Standards have been developed in accordance with the National Institute for Health and Care Excellence accreditation process

The brand new updated RPS Professional Standards for Hospital Pharmacy Services are now available.

 

The document replaces the 2014 version and provides a framework to improve current services, shape future services and roles and deliver safer, high quality patient care.

November 9, 2017
The survey highlighted that medicines used by patients across Europe have integrated supply chains

EFPIA has published results of a survey underlining the sheer scale and importance of the medicines issues that must be addressed as part of the Brexit discussions in order to protect public health.

 

Commenting on the survey, EFPIA Director General, Nathalie Moll said. “The survey underlines the  scale of the task ahead. For life saving and life improving medicines, the EU and UK cannot afford to wait any longer to ensure that the necessary cooperation on medicines is in place from the day the UK leaves the EU.”

May 31, 2016
The Falsified Medicines Directive, which requires complete compliance by February 2019 mandates the systematic authentication of medicines at the point of supply to the patient, in an effort to identify counterfeit, falsified, recalled or expired drugs

The sale of medicines known to be counterfeit or falsified is an unscrupulous business that endangers patient health. The Falsified Medicines Directive (FMD), which requires complete compliance by February 2019 mandates the systematic authentication (scanning) of medicines at the point of supply to the patient, in an effort to identify counterfeit, falsified, recalled or expired drugs. The FMD is a win-win-win for government, the pharmaceutical industry and patients, but it remains to be seen how this change will affect the secondary care environment.

October 29, 2015
Global awareness campaign calls for action to effect positive change for the many millions of people who live with psoriasis and psoriatic arthritis worldwide
October 15, 2015
VIEKIRAX + EXVIERA confirmed as cost effective treatment for adults with genotype 1 chronic hepatitis C virus (HCV) infection, including those with HIV/HCV co-infection, in NICE Final Appraisal Determination (FAD)

An estimated 214,000 people in the UK are chronically infected with hepatitis C (1), of which only an estimated 3% receive treatment in England each year (2).

 

September 30, 2015
The 75th International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences opened in Düsseldorf, Germany

At the opening ceremony, FIP President Carmen Peña, in her inaugural presidential address, called on pharmacists and pharmaceutical scientists around the world to ensure that the profession of pharmacy remains relevant and able to respond effectively to the current and future needs of the world’s communities.

 

September 30, 2015
The number of pharmacists per 10,000 population has grown around the world, according to a new report from the International Pharmaceutical Federation Education Initiative (FIPEd)

The publication, “Global pharmacy workforce intelligence: Trends report”, was released at the 75th World Congress of Pharmacy and Pharmaceutical Sciences. It is the fourth in a series of workforce reports produced every three years and contains a trend analysis of the three previous reports (2006, 2009, 2012), which covers 51 countries.
 

 

September 25, 2015
New report predicts learning together with other health professionals is becoming more mainstream

Learning together with other health professionals is becoming more mainstream for pharmacists and future pharmacists, according to a report published by the International Pharmaceutical Federation (FIP) Education Initiative.
 

September 15, 2015
Advice from Philip Newland-Jones, the Royal Pharmaceutical Society's Leadership Award winner

With the dramatic rise in the number of people living with type 2 diabetes there is an urgent need for more pharmacists who specialise in diabetes, the Royal Pharmaceutical Society's Leadership Award winner has advised.

 

Philip Newland-Jones, an Advanced Specialist Pharmacist Practitioner at University Hospital Southampton NHS Foundation Trust, won the award on Sunday 13 September for his outstanding leadership across several clinical, education and research fields within the area of diabetes, both locally and nationally.

September 10, 2015
Global standards of practice used by hospital pharmacists around the world have been revised

Global standards of practice used by hospital pharmacists around the world have been revised and are released by the Hospital Pharmacy Section (HPS) of the International Pharmaceutical Federation (FIP).
 

The standards, known as the "Basel Statements” and first published by the HPS in 2009, cover six main areas of hospital pharmacy:
 

August 10, 2015
The solution by Schreiner MediPharm and Edelmann: the package insert is easy to access by pharmacists and patients without affecting the first-opening protection of the pack

Schreiner MediPharm has developed in a joint project with the packaging manufacturer Edelmann an innovative solution that makes important product information accessible without opening the pharmaceutical pack. The packaging solution is based on the requirements of the EU Falsified Medicines Directive 2011/62/EU.

 

July 3, 2015
Duodopa® (Levodopa-carbidopa intestinal gel) recommended through NHSE’s specialised commissioning prioritisation process

AbbVie welcomes the decision by NHS England to approve Duodopa® (Levodopa-carbidopa intestinal gel – LCIG) for routine commissioning for the first time and to publish a clinical commissioning policy. Doctors in England will now be able to prescribe the treatment as an option for those people with advanced Parkinson’s who they consider to be suitable, in line with the new policy.

 

July 1, 2015
An important step towards the protection of healthcare workers and patients in situations of unrest was taken

An important step towards the protection of healthcare workers and patients in situations of unrest was taken when major global organisations for doctors, nurses and pharmacists adopted a set of new ethical principles.
 

 

June 26, 2015
Adults with non-radiographic axial spondyloarthritis can be considered for once-monthly subcutaneous injection with SIMPONI® (golimumab)

MSD (Merck & Co., Inc., Kenilworth, New Jersey, USA) announced that on 22 June the European Commission approved SIMPONI® (golimumab) for the treatment of adult patients with severe, active non-radiographic axial spondyloarthritis (nr-axial SpA). This follows CHMP positive opinion issued in May 2015, (1) based on the findings from the GO-AHEAD study, which demonstrated significant clinical improvement in patients with active nr-axial SpA treated with SIMPONI®, compared with patients treated with placebo, over 16 weeks. (2)

 

June 24, 2015
Internis Pharmaceuticals Ltd, launches a new MHRA-licenced and approved vitamin D formulation

Internis Pharmaceuticals Ltd, launches a new Medicines and Healthcare Related Products Agency (MHRA)-licenced and approved vitamin D (colecalciferol) formulation; the first commercially available on prescription for the treatment and prevention of vitamin D deficiency in children under five, pregnant women and breastfeeding mothers. Vitamin D deficiency is a serious and increasing UK public health priority, affecting up to 24% of the UK population. (1)

 

April 21, 2015
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organisation that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths in an impending "Antibiotic Armageddon” unless more is done to develop new cures, rapid diagnostics and preventative measures to combat the spread of drug resistant diseases.

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organisation that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths in an impending "Antibiotic Armageddon” unless more is done to develop new cures, rapid diagnostics and preventative measures to combat the spread of drug resistant diseases.

April 9, 2015
A new version of the Right Route: Right Care campaign launched today by Pfizer Healthy Partnerships (PHP) with endorsement from Pharmacy Voice, aims to support pharmacy teams in encouraging the public to make the most effective use of their local NHS services, using a simple traffic light system.

A new version of the Right Route: Right Care campaign launched today by Pfizer Healthy Partnerships (PHP) with endorsement from Pharmacy Voice, aims to support pharmacy teams in encouraging the public to make the most effective use of their local NHS services, using a simple traffic light system.
 

January 28, 2015
The UKCPA have announced that it commits to building and advancing working relationships with the pharmaceutical industry to improve patient care via the development of professional practice and pharmaceutical products.

The UKCPA have announced that it commits to building and advancing working relationships with the pharmaceutical industry to improve patient care via the development of professional practice and pharmaceutical products.

January 9, 2015
At the start of the new European Commission’s first full year of operation, the European Association of Hospital Pharmacists (EAHP) has issued a call to EU policy makers to make 2015 a year of action in meeting the antimicrobial resistance challenge.

At the start of the new European Commission’s first full year of operation, the European Association of Hospital Pharmacists (EAHP) has issued a call to EU policy makers to make 2015 a year of action in meeting the antimicrobial resistance challenge.

Publishing a new policy statement of its 34 national member associations, EAHP President Dr Roberto Frontini said:

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine